2009
DOI: 10.1093/ageing/afp015
|View full text |Cite
|
Sign up to set email alerts
|

The association between dehydroepiandosterone and frailty in older men and women

Abstract: we found an association between frailty and DHEAS levels. Whether the association is due to similar conditions resulting in lower DHEA levels and more susceptibility to frailty or whether lower DHEA levels have an impact on increasing frailty cannot be addressed by cross-sectional analysis. Gender did not impact the association between DHEAS and frailty, but obesity (BMI > 30 kg/m(2)) attenuated the association between higher DHEA levels and lower frailty status.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
42
2
3

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(54 citation statements)
references
References 32 publications
(38 reference statements)
7
42
2
3
Order By: Relevance
“…Hormonal interventions have typically been explored as a treatment for muscle wasting based on the cross-sectional associations between circulating hormone concentrations and skeletal muscle mass and characteristics of frailty in older men and women [179,180]. However, when hormonal interventions have been implemented, they seldom demonstrate efficacy for improving muscle functioning.…”
Section: Hormonal Interventionsmentioning
confidence: 99%
See 1 more Smart Citation
“…Hormonal interventions have typically been explored as a treatment for muscle wasting based on the cross-sectional associations between circulating hormone concentrations and skeletal muscle mass and characteristics of frailty in older men and women [179,180]. However, when hormonal interventions have been implemented, they seldom demonstrate efficacy for improving muscle functioning.…”
Section: Hormonal Interventionsmentioning
confidence: 99%
“…Moreover, studies administering hormonal treatments for treatment of sarcopenia in older adults have seldom reported muscle qualitative outcomes. Thus, although serum levels of the adrenal steroid hormone dehydroepiandrosterone (DHEA) [181] are associated with frailty characteristics in older adults [179], administration of exogenous DHEA supplementation does not appear to benefit measures of physical function or performance [182]. Similarly, while circulating estradiol is associated with skeletal muscle mass in older women [180], estrogen replacement therapy does not appear to protect against the muscle loss of aging [183].…”
Section: Hormonal Interventionsmentioning
confidence: 99%
“…Perhaps this is due to the fact that DHEA levels need to be monitored over many years. Obesity appears to attenuate the association or correlation between higher DHEA and lower morbidity [216].…”
Section: First Do No Harm: Potentially Harmful or Ineffective Nutracementioning
confidence: 95%
“…Age-related declines in insulin-like growth factor-1 (IGF-1), DHEAS, and gonadal steroids have been implicated in the pathogenesis of frailty and are thought to contribute to changes in anabolic metabolism and leukocyte function [45, 52, 53]. One recent prospective study of community-dwelling seniors demonstrated that higher baseline cortisol to DHEAS ratios (cortisol:DHEAS) and leukocyte counts were predictive of frailty at 10-year follow up (AUC=0.70) [43**].…”
Section: Pathophysiologymentioning
confidence: 99%